z-logo
open-access-imgOpen Access
P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA‐DIRECTED CAR T‐CELL THERAPY
Author(s) -
Ortiz De Landazuri I.,
OliverCaldés A.,
EspañolRego M.,
Contreras M. T.,
Zabaleta A.,
Agulló C.,
Puig N.,
Cabañas V.,
GonzálezCalle V.,
Jiménez R.,
Inogés S.,
RodríguezOtero P.,
MartinAntonio B.,
Reguera J. L.,
LópezDiaz de Cerio A.,
BenítezRibas D.,
RodríguezLobato L. G.,
González E. A.,
Rosiñol L.,
Yagüe J.,
Moraleda J. M.,
UrbanoIspizua Á.,
Mateos M. V.,
Juan M.,
Paiva B.,
Pascal M.,
Fernández de Larrea C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846328.56229.e7
Subject(s) - daratumumab , medicine , multiple myeloma , immunofixation , refractory (planetary science) , gastroenterology , monoclonal , antibody , monoclonal antibody , immunology , lenalidomide , astrobiology , physics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here